Dagode, Salvacion L.
HRN: 12-71-83 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/09/2023
MUPIROCIN 2%, 15G (TUBE)
11/09/2023
11/15/2023
IVTT
Apply On Affected Areas
Bid
T/c Staphylococcal Skin Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes